1MVF
MazE addiction antidote
Summary for 1MVF
Entry DOI | 10.2210/pdb1mvf/pdb |
Descriptor | immunoglobulin heavy chain variable region, PemI-like protein 1 (3 entities in total) |
Functional Keywords | plasmid addiction, camel antibody, addiction antidote, immune system |
Biological source | Camelus dromedarius (Arabian camel) More |
Total number of polymer chains | 4 |
Total formula weight | 48516.33 |
Authors | Loris, R.,Marianovsky, I.,Lah, J.,Laeremans, T.,Engelberg-Kulka, H.,Glaser, G.,Muyldermans, S.,Wyns, L. (deposition date: 2002-09-25, release date: 2003-06-10, Last modification date: 2024-10-30) |
Primary citation | Loris, R.,Marianovsky, I.,Lah, J.,Laeremans, T.,Engelberg-Kulka, H.,Glaser, G.,Muyldermans, S.,Wyns, L. Crystal structure of the intrinsically flexible addiction antidote MazE. J.Biol.Chem., 278:28252-28257, 2003 Cited by PubMed Abstract: A specific camel VHH (variable domain of dromedary heavy chain antibody) fragment was used to crystallize the intrinsically flexible addiction antidote MazE. Only 45% of the polypeptide chain is found ordered in the crystal. The MazE monomer consisting of two beta-hairpins connected by a short alpha-helix has no hydrophobic core on its own and represents only one half of a typical protein domain. A complete domain structure is formed by the association of two chains, creating a hydrophobic core between two four-stranded beta-sheets. This hydrophobic core consists exclusively of short aliphatic residues. The folded part of MazE contains a novel DNA binding motif. A model for DNA binding that is consistent with the available biochemical data is presented. PubMed: 12743116DOI: 10.1074/jbc.M302336200 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.65 Å) |
Structure validation
Download full validation report